DICERNA
Live / Registered — Registered (as of 18 Jul 2023)
What this means for you
Registered since 18 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88694422
- Registration number
- 7115639
- Mark type
- Word mark
- Filed
- 15 Nov 2019
- Published for opposition
- 31 Mar 2020
- Registered
- 18 Jul 2023
- Attorney of record
- Bridget H. Labutta
Goods and services
- Class 042 — Scientific and technological services: Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Owner
- Dicerna Pharmaceuticals, Inc., Lexington, MA, US
- Dicerna Pharmaceuticals, Inc., Lexington, MA, US
- Dicerna Pharmaceuticals, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 18 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 31 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 26 May 2023 — USE AMENDMENT FILED
- 26 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 07 Feb 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Feb 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Feb 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2022 — SOU EXTENSION 5 GRANTED
- 22 Nov 2022 — SOU EXTENSION 5 FILED
- 02 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Nov 2022 — SOU TEAS EXTENSION RECEIVED